HHS Tells Judge Unwinding Medicare Payment Cuts for 340B Drugs Needs Caution, Not Haste

USDC DC empty courtroom interior
HHS urged a federal district court in Washington, D.C., late last week not to order it to expedite a legal brief in the lawsuit over deep Medicare payment cuts for hospitals' 340B-purchased drugs.

The U.S. Health and Human Services Department (HHS) asked a federal district judge late last week not to make it rush its response to hospitals’ request for an immediate halt to a nearly 30% Medicare Part B payment cut in

Read More »

HRSA Grants 340B Enrollment Flexibility in Kentucky Due to Floods

American Red Cross disaster relief worker standing in debris
Due to severe flooding in eastern Kentucky, HRSA is letting eligible providers in the state enroll in 340B on an expedited basis.

The U.S. Health Resources and Services Administration (HRSA) is letting eligible healthcare providers in flood-devastated Kentucky enroll in the 340B program immediately instead of making them wait until the next quarterly enrollment period in October.

U.S. Health and Human Services

Read More »

Senate Rejects 340B-Related Amendment to Major Drug Pricing and Climate Change Bill

Sen. John Kennedy (R-LA) speaking on Senate floor
U.S. Sen. John Kennedy's (R-La.) failed amendment to the Inflation Reduction Act would have required health centers to make insulin and EpiPens available at or below 340B price and would have helped cover centers' direct costs of doing so. A leading health center advocate panned the amendment.

The U.S. Senate on Sunday rejected a Republican amendment to Democratic drug pricing and climate change legislation that would have required federally qualified health centers to make insulin and injectable epinephrine available to patients at or below 340B price.

But

Read More »

Senate Passes Historic Bill that Would Let Medicare Negotiate Some Drugs’ Prices

Sen. Chuck Schumer (D-NY) speaking on Senate floor
Senate Majority Leader Chuck Schumer (D-N.Y.) opens debate Sunday on historic legislation that would let Medicare negotiate prices on a small number of high-cost single-source drugs. The House is expected to pass the bill this Friday.

The U.S. Senate on Sunday passed historic legislation to let Medicare negotiate the prices of a small number of costly medicines and require drug manufacturers to pay Medicare rebates when prices paid by Medicare rise faster than inflation.

Language in

Read More »

Providers March on U.S. Capitol Grounds to “Defend 340B”

340B program advocates with signs in front of the US Capitol building
Safety-net provider advocates marched on the U.S. Capitol grounds yesterday to raise awareness about threats to the 340B drug pricing program.

About 100 safety-net provider advocates marched and chanted yesterday on the grounds of the U.S. Capitol to raise awareness in Congress and beyond about threats to the 340B drug pricing program.

The demonstration, organized by Community Voices for 340B (CV340B),

Read More »

Ex-Surgeon General Adams Urges 340B Entities to Publicize Program’s Benefits

Former U.S. Surgeon General Jerome Adams speaking at a conference
Ex-U.S. Surgeon General Jerome Adams urged 340B Coalition summer conference attendees to show they "are fighting to deliver care to the vulnerable and to the underserved." | Credit: 340B Coalition Twitter

Healthcare providers can suppress attacks on and build support for the 340B program by doing more to show the program helps vulnerable patients, the anesthesiologist who served as President Trump’s surgeon general said yesterday.

“We are fighting to deliver care

Read More »

340B Hospitals Ask Judge to Stop Part B Drug Payment Cuts Immediately

hypodermic needle and glass ampule
Groups that represent 340B hospitals asked a federal district judge to immediately halt a nearly 30% Medicare Part B payment cut for hospitals’ 340B-purchased drugs.

Groups that represent 340B hospitals yesterday asked a federal district judge in Washington, D.C., to immediately halt a nearly 30% Medicare Part B payment cut in place since 2018 for hospitals’ 340B-purchased drugs.

American Hospital Association, America’s Essential Hospitals, Association

Read More »

Purdue Pharma Is Providing 340B Refunds Spanning 16 Years of Overcharges

A bottle of Betasept antiseptic scrub
Purdue Pharma announced refunds for 340B overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—more than half of the 340B program's existence.

Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021. That period covers more than half of the 340B program’s existence.

During

Read More »

Senate Democrats Say They Are on Track to Pass Drug Pricing Bill Before Aug. 8

U.S. Senate chamber viewed from public gallery
Senate Democrats are still pushing to pass drug pricing legislation before the chamber begins its summer break on Aug. 8.

Senate Democrats said yesterday they would know this week whether an updated Senate drug pricing bill meets the criteria for passage via budget reconciliation, which requires just 50 Democratic votes. The bill remains on track for a floor vote before

Read More »

HRSA Unveils New 340B Contract Pharmacy Services Webpage That Is Silent on Manufacturer Obligations

screenshot of HRSA contract pharmacy services
HRSA has posted a new 340B Contract Pharmacy Services webpage that addresses requirements for covered entities but not for pharmaceutical manufacturers.

The U.S. Health Resources and Services Administration overnight unveiled a new Contract Pharmacy Services page on the 340B program website that addresses requirements for covered entities but not for pharmaceutical manufacturers.

The webpage links to HRSA’s 2010 contract pharmacy final

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report